Your browser doesn't support javascript.
loading
Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapy.
Friedlander, Michael; Matulonis, Ursula; Gourley, Charlie; du Bois, Andreas; Vergote, Ignace; Rustin, Gordon; Scott, Clare; Meier, Werner; Shapira-Frommer, Ronnie; Safra, Tamar; Matei, Daniela; Shirinkin, Vadim; Selle, Frédéric; Fielding, Anitra; Lowe, Elizabeth S; McMurtry, Emma L; Spencer, Stuart; Rowe, Philip; Mann, Helen; Parry, David; Ledermann, Jonathan.
Afiliación
  • Friedlander M; University of New South Wales Clinical School, Prince of Wales Hospital, Randwick, NSW, Australia. Michael.friedlander@health.nsw.go.au.
  • Matulonis U; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Gourley C; Cancer Research UK Edinburgh Centre, Western General Hospital, Edinburgh, UK.
  • du Bois A; Kliniken Essen Mitte, Essen, Germany.
  • Vergote I; University of Leuven, Leuven Cancer Institute, Leuven, Belgium.
  • Rustin G; Mount Vernon Hospital, Northwood, UK.
  • Scott C; Royal Melbourne Hospital, Parkville, VIC, Australia.
  • Meier W; University of Düsseldorf, Düsseldorf, Germany.
  • Shapira-Frommer R; Chaim Sheba Medical Center, Tel Hashomer, Israel.
  • Safra T; Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Matei D; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Shirinkin V; Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Selle F; Orenburg Regional Clinical Oncological Dispensary, Orenburg, Russia.
  • Fielding A; Groupe Hospitalier Diaconesses Croix Saint-Simon, Paris, France.
  • Lowe ES; GINECO Group, Paris, France.
  • McMurtry EL; AstraZeneca, Cambridge, UK.
  • Spencer S; AstraZeneca, Gaithersburg, MD, USA.
  • Rowe P; AstraZeneca, Gaithersburg, MD, USA.
  • Mann H; AstraZeneca, Cambridge, UK.
  • Parry D; AstraZeneca, Cambridge, UK.
  • Ledermann J; AstraZeneca, Cambridge, UK.
Br J Cancer ; 119(9): 1075-1085, 2018 10.
Article en En | MEDLINE | ID: mdl-30353045
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Ftalazinas / Piperazinas / Cistadenocarcinoma Seroso / Recurrencia Local de Neoplasia / Antineoplásicos Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Br J Cancer Año: 2018 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Ftalazinas / Piperazinas / Cistadenocarcinoma Seroso / Recurrencia Local de Neoplasia / Antineoplásicos Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Br J Cancer Año: 2018 Tipo del documento: Article País de afiliación: Australia